CoChat

Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

In individuals with type 2 diabetes with abdominal obesity, hyperfiltration is a risk factor for accelerated glomerular filtration rate (GFR) decline and nephropathy. In this academic, single-center, parallel-group, prospective, randomized, open-label, blinded end point trial, consenting patients with type 2 diabetes aged >18 years, with waist circumference >94 (males) or >80 (females) cm, serum creatinine <1.2 mg/dL, and normoalbuminuria were randomized (1:1) with permuted blocks to 6 months of a 25% calorie restricted (CR) or standard diet (SD). Primary outcome was measured GFR (iohexol plasma clearance). Analyses were by modified intention to treat. At 6 months, GFR significantly decreased in 34 patients on CR and did not change appreciably in 36 on SD. Changes were significantly different between the groups. GFR and body weight reduction were correlated. GFR reduction was larger in hyperfiltering (GFR >120 mL/min) than nonhyperfiltering patients and was associated with BMI, waist circumference, blood pressure, heart rate, HbA1c, blood glucose, LDL-to-HDL cholesterol ratio, C-reactive protein, angiotensin II, and albuminuria reduction and with increased glucose disposal rate (measured by hyperinsulinemic-euglycemic clamps). Protein and sodium intake and concomitant treatments were similar between the groups. CR was tolerated well. In patients with type 2 diabetes with abdominal obesity, CR ameliorates glomerular hyperfiltration, insulin sensitivity, and other cardiovascular risk factors, effects that might translate into long-term nephro- and cardioprotection.

Overview

Integrity signals

Registry

Crossref · 10.2337/db16-0607

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Cited by

See all 95

Metadata

Authors
Ruggenenti, P., Abbate, M., Ruggiero, B., Rota, S., Trillini, M., Aparicio, C., Parvanova, A., Petrov Iliev, I., Pisanu, G., Perna, A., Russo, A., Diadei, O., Martinetti, D., Cannata, A., Carrara, F., Ferrari, S., Stucchi, N., Remuzzi, G., Fontana, L., & on behalf of the C.RE.S.O. Study Group
Affiliations
  • Mario Negri Institute for Pharmacological Research (IT)
  • Ospedale Papa Giovanni XXIII (IT)
  • IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro di Ricerche Cliniche per le Malattie Rare “Aldo e Cele Daccò,” Bergamo, Italy
  • University of Milan (IT)
  • Washington University in St. Louis (US)
Corresponding author
Remuzzi, Giuseppe
Venue
Diabetes
Published
2016-09-15
Volume
66
Issue
1
Pages
75-86
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2460846739
Cited by
95
References
40
Citations by year
2026: 3 · 2025: 11 · 2024: 14 · 2023: 11 · 2022: 15 · 2021: 15 · 2020: 12 · 2019: 6 · 2018: 4 · 2017: 2 · 2016: 2
FWCI
4.70
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
Funders
  • Italian Ministry of Health
  • Bakewell Foundation
  • Longer Life Foundation
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
caloric restriction, type 2 diabetes, abdominal obesity, glomerular hyperfiltration, glomerular filtration rate, renal function, insulin sensitivity, albuminuria, weight loss, cardiovascular risk factors, renal protection, cardioprotection
MeSH terms
Aged, Angiotensin II, Body Weight, C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney Function Tests, Male, Middle Aged, Risk Factors, Caloric Restriction, Obesity, Abdominal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.